← Back to Clinical Trials
Recruiting NCT05630508

NCT05630508 Lifestyle Management App for Adults With Diabetes Type

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05630508
Status Recruiting
Phase
Sponsor Princess Nourah Bint Abdulrahman University
Condition Diabetes Mellitus, Type 2
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2022-10-01
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
interactive Mhealth Lifestyle behavior interventionSham

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2022-10-01 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study will evaluate whether the 12-week health coaching mobile application (LIVEN) will succeed in enhancing lifestyle behaviors in adults with Type 2 Diabetes compared to typical treatment. The mobile application's viability will be assessed in 2 parts; the first part is testing easiness and friendliness of using Liven by the patient and health coach. The second part is evaluating the suitability of Liven education material for the patients and whether the coaching program results in enhancing lifestyle behaviors and blood sugar levels. the investigators hypothesize that the 12-week online lifestyle-coaching program will be viable, and a full-scale study can proceed.

Eligibility Criteria

Inclusion Criteria: * Adults, aged 18 years or older * Arabic speakers * Capable of utilizing smartphones * Diagnosed with T2DM * Poor glycemic control: A1c \> 7.5% Exclusion Criteria: * Individuals using insulin injection * Individuals suffering from disorders that might affect intervention (e.g. amputation, enucleation of the eye, or end-stage kidney disease) * Women who are pregnant or breastfeeding * Individuals diagnosed with other types of diabetes (such as type I or MODY)

Contact & Investigator

Central Contact

Shaima A Alothman, PhD

✉ shaalothman@pnu.edu.sa

📞 +966503952053

Frequently Asked Questions

Who can join the NCT05630508 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05630508 currently recruiting?

Yes, NCT05630508 is actively recruiting participants. Contact the research team at shaalothman@pnu.edu.sa for enrollment information.

Where is the NCT05630508 trial being conducted?

This trial is being conducted at Riyadh, Saudi Arabia.

Who is sponsoring the NCT05630508 clinical trial?

NCT05630508 is sponsored by Princess Nourah Bint Abdulrahman University. The trial plans to enroll 90 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology